UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Annals of hematology, 2017-11, Vol.96 (11), p.1775-1792

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Annals of hematology, 2013-04, Vol.92 (4), p.433-442

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

Leukemia, 2014-05, Vol.28 (5), p.1001-1007

2014

Link zum Volltext

Verfügbarkeit prüfen

Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)

Annals of oncology, 2006-07, Vol.17 (7), p.1051-1059

2006

Link zum Volltext

Verfügbarkeit prüfen

Incidence and severity of ifosfamide-induced encephalopathy

Anti-cancer drugs, 2004-04, Vol.15 (4), p.347-350

2004

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic pitfalls in antifungal treatment

Annals of hematology, 2004, Vol.83 Suppl 1, p.S40-S40

Schiel, X

2004

Link zum Volltext

Verfügbarkeit prüfen

Successful salvage high-dose chemotherapy and autologous stem-cell transplantation in HIV-related germ-cell tumor

Annals of oncology, 2009-11, Vol.20 (11), p.1900-1901

2009

Link zum Volltext

Verfügbarkeit prüfen

Recent trends of Candida epidemiology in cancer and non-cancer patients

International journal of infectious diseases, 2010, Vol.14, p.e117-e117

2010

Link zum Volltext

Verfügbarkeit prüfen

A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II

Infection, 2006-06, Vol.34 (3), p.118-126

2006

Link zum Volltext

Verfügbarkeit prüfen

Dokumentierte Infektionen bei Neutropenie - Empfehlungen zu Diagnostik und Therapie

Deutsche medizinische Wochenschrift, 2001-09, Vol.126 (39), p.1085-1090

2001

Link zum Volltext

Verfügbarkeit prüfen

Unexpected toxicity (UT) and opportunistic infections (OI) after rituximab-containing therapy for non-Hodgkin's lymphoma (NHL)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e19546-e19546

2009

Link zum Volltext

Verfügbarkeit prüfen

Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia

European journal of medical research, 2002-11, Vol.7 (11), p.487

2002

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial therapy of unexplained fever in neutropenic patients

Annals of hematology, 2003-10, Vol.82, p.S105-S117

2003

Link zum Volltext

Verfügbarkeit prüfen

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

Annals of hematology, 2012-07, Vol.91 (7), p.1051-1063

2012

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-1β induces synthesis and secretion of interleukin-6 in human chondrocytes

FEBS letters, 1990-04, Vol.263 (2), p.321-324

1990

Link zum Volltext

Verfügbarkeit prüfen

European surveillance of infections and risk factors in cancer patients

European journal of clinical microbiology & infectious diseases, 1999-02, Vol.18 (2), p.161-163

1999

Link zum Volltext

Verfügbarkeit prüfen

European Surveillance of Infections in Cancer Patients – ESIC

Chemotherapy (Basel), 1999-07, Vol.45 (4), p.237-241

1999

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine + cisplatin (GEM+CIS) in combination with regional hyperthermia (RHT) in second-line therapy of gemcitabine-refractory metastatic pancreatic cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14073-14073

2006

Link zum Volltext

Verfügbarkeit prüfen

Incidence and severity of ifosfamide-induced encephalopathy

Anti-cancer drugs, 2004-04, Vol.15 (4), p.347-350

2004

Link zum Volltext

Verfügbarkeit prüfen

Infektiologische Notf lle in der Onkologie

Der Internist (Berlin), 2005-01, Vol.46 (1), p.39-47

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies

Clinical chemistry (Baltimore, Md.), 1998-02, Vol.44 (2), p.408-414

1998

Link zum Volltext

Verfügbarkeit prüfen

Interventional antimicrobial therapy for febrile complications after high-dose chemotherapy and autologous stem cell transplantation. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology

Deutsche medizinische Wochenschrift, 1999-04, Vol.124 Suppl 1, p.S9-13

1999

Link zum Volltext

Verfügbarkeit prüfen

CLINICAL AND ECONOMIC BENEFIT BY OPTIMIZED AMINOGLYCOSIDE THERAPY IN NEUTROPENIC PATIENTS WITH FEVER OF UNKNOWN ORIGIN

Therapeutic drug monitoring, 1999-08, Vol.21 (4), p.454

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Male
(11)
Adult
(10)
Female
(9)
Oncology
(9)
Aged
(8)
Biological And Medical Sciences
(8)
Middle Aged
(8)
Hematology
(6)
Adolescent
(5)
Medical Sciences
(5)
Neoplasms - Complications
(5)
Neoplasms - Drug Therapy
(5)
Aged, 80 And Over
(4)
Antineoplastic Agents - Adverse Effects
(4)
Cancer
(4)
Chemotherapy
(4)
Fever
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO)

Incidence and severity of ifosfamide-induced encephalopathy

Pharmacodynamic pitfalls in antifungal treatment

Successful salvage high-dose chemotherapy and autologous stem-cell transplantation in HIV-related germ-cell tumor

Recent trends of Candida epidemiology in cancer and non-cancer patients

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II

Dokumentierte Infektionen bei Neutropenie - Empfehlungen zu Diagnostik und Therapie

Unexpected toxicity (UT) and opportunistic infections (OI) after rituximab-containing therapy for non-Hodgkin's lymphoma (NHL)

Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia

Antimicrobial therapy of unexplained fever in neutropenic patients

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

Interleukin-1β induces synthesis and secretion of interleukin-6 in human chondrocytes

European surveillance of infections and risk factors in cancer patients

European Surveillance of Infections in Cancer Patients – ESIC

Gemcitabine + cisplatin (GEM+CIS) in combination with regional hyperthermia (RHT) in second-line therapy of gemcitabine-refractory metastatic pancreatic cancer

Incidence and severity of ifosfamide-induced encephalopathy

Infektiologische Notf lle in der Onkologie

Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies

Interventional antimicrobial therapy for febrile complications after high-dose chemotherapy and autologous stem cell transplantation. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology

CLINICAL AND ECONOMIC BENEFIT BY OPTIMIZED AMINOGLYCOSIDE THERAPY IN NEUTROPENIC PATIENTS WITH FEVER OF UNKNOWN ORIGIN

Suchergebnisse filtern